Emergent BioSolutions (EBS) Interest & Investment Income (2011 - 2018)
Emergent BioSolutions (EBS) posted quarterly Interest & Investment Income of $701000.0 for Q3 2018, up 10.05% year-over-year from $637000.0 in Q3 2017, and up 129.08% quarter-over-quarter from $306000.0 in Q2 2018.
Emergent BioSolutions (EBS) Interest & Investment Income (2011 - 2018) Analysis & Trends
Emergent BioSolutions' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $701000.0 for Q3 2018.
- In Q3 2018, Interest & Investment Income rose 10.05% year-over-year to $701000.0; the TTM figure through Sep 2018 stood at $1.4 million (down 26.2% YoY), while the FY2017 annual figure was $1.8 million, up 66.48% from the prior year.
- Interest & Investment Income for Q3 2018 stood at $701000.0, up from $306000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $2.7 million in Q4 2014, with the low at $31000.0 in Q2 2014.
- The 5-year median for Interest & Investment Income is $222000.0 (2018), against an average of $393947.4.
- The sharpest annual moves came in 2014 and 2015: Interest & Investment Income jumped 15172.22% in 2014, then plunged 95.89% in 2015.
- Emergent BioSolutions' Interest & Investment Income stood at $2.7 million in 2014, then slumped by 95.89% to $113000.0 in 2015, then soared by 155.75% to $289000.0 in 2016, then plunged by 44.64% to $160000.0 in 2017, then surged by 338.12% to $701000.0 in 2018.
- Business Quant data shows EBS's Interest & Investment Income at $701000.0 in Q3 2018, $306000.0 in Q2 2018, and $222000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 701,000.00 |
| Jun 30, 2018 | 306,000.00 |
| Mar 31, 2018 | 222,000.00 |
| Dec 31, 2017 | 160,000.00 |
| Sep 30, 2017 | 637,000.00 |
| Jun 30, 2017 | 583,000.00 |
| Mar 31, 2017 | 373,000.00 |
| Dec 31, 2016 | 289,000.00 |
| Sep 30, 2016 | 358,000.00 |
| Jun 30, 2016 | 219,000.00 |
| Mar 31, 2016 | 186,000.00 |
| Dec 31, 2015 | 113,000.00 |
| Sep 30, 2015 | 104,000.00 |
| Jun 30, 2015 | 273,000.00 |
| Mar 31, 2015 | 82,000.00 |
| Dec 31, 2014 | 2.75 Mn |
| Sep 30, 2014 | 59,000.00 |
| Jun 30, 2014 | 31,000.00 |
| Mar 31, 2014 | 40,000.00 |
| Dec 31, 2013 | 18,000.00 |